Cash Flow Statement
Growth Metrics

Mimedx (MDXG) Non-cash Items (2011 - 2013)

Mimedx recorded quarterly Non-cash Items of $15.6 million in Q1 2013, up 154.29% quarter-over-quarter from $6.2 million in Q4 2012.

Mimedx's Non-cash Items history runs 3 years deep, the most recent figure standing at $15.6 million for Q1 2013.

  • In Q1 2013, Non-cash Items changed N/A year-over-year to $15.6 million; the TTM figure through Mar 2013 stood at $15.6 million (changed N/A YoY), while the FY2012 annual figure was $6.2 million, up 322.11% from the prior year.
  • Non-cash Items came in at $15.6 million for Q1 2013 at Mimedx, up from $6.2 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $15.6 million in Q1 2013 to a low of $1.5 million in Q4 2011.
  • A 3-year average of $8.0 million and a median of $6.2 million in 2012 frame the typical range for Non-cash Items.
  • On a YoY basis, Non-cash Items climbed as much as 322.11% in 2012 and fell as far as 322.11% in 2012.
  • Mimedx's Non-cash Items stood at $1.5 million in 2011, then soared by 322.11% to $6.2 million in 2012, then jumped by 154.29% to $15.6 million in 2013.
  • According to Business Quant data, Non-cash Items over the past three periods registered $15.6 million, $6.2 million, and $12.4 million for Q1 2013, Q4 2012, and Q3 2012 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Mimedx 530.69 Mn 370.92 Mn 41.62 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2013 15.64 Mn
Mar 31, 2013 15.64 Mn
Dec 31, 2012 6.15 Mn
Dec 31, 2012 6.15 Mn
Sep 30, 2012 12.43 Mn
Sep 30, 2012 12.43 Mn
Jun 30, 2012 4.12 Mn
Jun 30, 2012 4.12 Mn
Dec 31, 2011 1.46 Mn
Dec 31, 2011 1.46 Mn